Global demand for the cold plasma market was valued at approximately USD 1,146.9 million in 2018 and is expected to generate around USD 3,226.8 million by the end of 2025, growing at a CAGR of around 15.9% between 2019 and 2025.
The report covers forecast and analysis for the global cold plasma market. The study provides historic data from 2016 to 2018 along with forecasts from 2019 to 2025 based on revenue (USD Million). In-depth secondary research is used to ascertain overall market size, top industry players, top products, industry associations, etc. Macro-economic indicators such as healthcare industry outlook, healthcare spending, research funding, GDP along with company websites, company annual reports, white papers, financial reports, and other sources have also been considered to arrive at the indicated market numbers.
Non-equilibrium plasma or cold plasma is considered the fourth state of matter. It has a large number of applications in various industries like bioengineering, medical, and therapeutics. It is used in the treatment of living biological tissues, sterilization of biomedical surfaces, and surface modification of biomedical materials and devices due to its bactericidal and antimicrobial properties.
The study provides a decisive view of the cold plasma market by segmenting the market based on regime, application, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2019 to 2025. Based on the regime the market is bifurcated into low-pressure cold plasma and atmospheric cold plasma. The devices segment held a major share of the market in 2018. The market for atmospheric cold plasma held the major share of the market in 2018. It is a new technology with wide applications in the healthcare sector like wound healing, infection control, and burn treatment. It also has its applications in non-surgical and surgical procedures.
Based on application the market is segmented into wound healing, blood coagulation, dentistry, cancer treatment, and other medical applications. The cancer treatment is likely to grow at a high CAGR in the forecast period owing to one of the breakthrough technologies in the application for this treatment. The technology has shown efficacy in the pre-clinical models of various cancers like the skin, lung, brain, bladder, breast, neck, and head cancer. Besides, in-vivo and in-vitro studies also reveal that cancer cells are effectively killed by cold plasma, by decreasing the velocity of cell migration, which has an important implication in the disease treatment. Regional segmentation includes the current and forecast demand for Asia Pacific, North America, Latin America, Europe, and Middle East & Africa with its further bifurcation into major countries. North America held major share of the market due to the availability of various FDA-approved products and the presence of key industry participants in this region.
The study also includes drivers and restraints for the cold plasma along with the impact they have on the demand over the forecast period. Besides, the report includes the study of opportunities and trends available in the cold plasma market on global level. The demand for cold plasma is rising due to its extensive usage in medical treatments. Besides, rising cases of HAIs i.e. Hospital Acquired Infections due to the lack of precaution and sanitation are likely to boost the demand for cold plasma in the forecast period. Cold plasma exhibits antiviral, antifungal, and antimicrobial properties which help in the elimination of HAIs. However, huge capital is required to implement this technology which is restraining market growth.
The report also provides a company market share analysis in order to give a broader view of the key players in the market. Industry insights and information is delivered in the required format. ZMR develops a list of industry players (manufacturers), distributors, retailers and industry experts. Some of the players included in the cold plasma market are Apyx Medical Corporation, COMET Plasma Control Technologies, Neoplas Tools GmbH, Henniker Plasma, U.S. Medical Innovations (USMI), LLC, Europlasma N.V., Bovie Medical Corporation, and P2i Limited.
The report segments the cold plasma market as follows:
Global Cold Plasma Market: Regime Segment Analysis
Global Cold Plasma Market: Application Segment Analysis
Global Cold Plasma Market: Regional Segment Analysis